Skip to main content

Corporate insider profile

Jason Aryeh Insider Trades

Jason Aryeh has reported 2 open-market purchases on SEC Form 4 and is a net seller of $2,939,056 across 2 companies. The most recent open-market transaction was reported on Nov 10, 2026. Source: SEC Form 4 filings.

Latest reported as Corporate insider of LIGAND PHARMACEUTICALS INC (LGND).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
2
Reported companies
2
Net open-market value
-$2,939,055.69
Latest transaction
Nov 10, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 10, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale3,000$320.05$960,141
Nov 4, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale282$319.99$90,237
Nov 2, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale2,111$320.30$676,158
Jun 11, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale5,000$250.00$1,250,000
May 18, 2026Orchestra BioMed Holdings, Inc. (OBIO)Corporate insiderOpen Market Purchase665$3.75$2,494
May 15, 2026Orchestra BioMed Holdings, Inc. (OBIO)Corporate insiderOpen Market Purchase8,971$3.90$34,987

Common questions

Jason Aryeh insider trading FAQ

Is Jason Aryeh buying or selling stock?
Across all SEC Form 4 open-market filings on record, Jason Aryeh is a net seller of $2,939,056, with 2 open-market purchases reported. The latest transaction was reported on Nov 10, 2026.
Which companies does Jason Aryeh report insider trades for?
Jason Aryeh has reported open-market trades in LIGAND PHARMACEUTICALS INC (LGND), Orchestra BioMed Holdings, Inc. (OBIO). The latest SEC-reported relationship is Corporate insider of LIGAND PHARMACEUTICALS INC (LGND).
Where does Jason Aryeh's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1376960, and refreshes this page daily.